Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms | 6 | 2024 | 1103 | 2.290 |
Why?
|
Asthma | 6 | 2020 | 380 | 2.070 |
Why?
|
Mental Health | 6 | 2023 | 303 | 1.390 |
Why?
|
Chronic Disease | 3 | 2021 | 484 | 1.350 |
Why?
|
Telemedicine | 2 | 2020 | 182 | 1.100 |
Why?
|
Adult | 21 | 2024 | 11712 | 1.040 |
Why?
|
Trust | 2 | 2023 | 133 | 0.990 |
Why?
|
Humans | 42 | 2024 | 37093 | 0.980 |
Why?
|
United States | 17 | 2024 | 4223 | 0.920 |
Why?
|
Female | 27 | 2024 | 20969 | 0.910 |
Why?
|
Middle Aged | 20 | 2024 | 10129 | 0.900 |
Why?
|
Information Seeking Behavior | 2 | 2020 | 26 | 0.880 |
Why?
|
Residence Characteristics | 3 | 2023 | 322 | 0.870 |
Why?
|
Health Behavior | 3 | 2021 | 537 | 0.840 |
Why?
|
Poverty | 2 | 2016 | 348 | 0.830 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 664 | 0.780 |
Why?
|
Immunocompromised Host | 1 | 2021 | 22 | 0.780 |
Why?
|
Hypersensitivity | 1 | 2021 | 30 | 0.760 |
Why?
|
Health Surveys | 2 | 2020 | 373 | 0.750 |
Why?
|
Male | 22 | 2024 | 20025 | 0.750 |
Why?
|
Communicable Disease Control | 1 | 2021 | 32 | 0.750 |
Why?
|
Electronic Health Records | 1 | 2021 | 66 | 0.750 |
Why?
|
Health Care Surveys | 1 | 2020 | 136 | 0.740 |
Why?
|
Consumer Health Information | 1 | 2020 | 22 | 0.730 |
Why?
|
Healthcare Disparities | 2 | 2024 | 494 | 0.690 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 2721 | 0.660 |
Why?
|
Internet | 1 | 2020 | 211 | 0.660 |
Why?
|
Young Adult | 12 | 2021 | 4268 | 0.650 |
Why?
|
Adolescent | 12 | 2021 | 5363 | 0.630 |
Why?
|
September 11 Terrorist Attacks | 1 | 2017 | 25 | 0.600 |
Why?
|
Career Mobility | 1 | 2017 | 24 | 0.600 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 441 | 0.590 |
Why?
|
Mental Disorders | 1 | 2021 | 309 | 0.590 |
Why?
|
Employment | 1 | 2017 | 76 | 0.580 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 336 | 0.560 |
Why?
|
Public Housing | 1 | 2016 | 15 | 0.550 |
Why?
|
Demography | 3 | 2023 | 175 | 0.500 |
Why?
|
Health Services Accessibility | 1 | 2019 | 560 | 0.480 |
Why?
|
Allergens | 1 | 2014 | 63 | 0.470 |
Why?
|
Air Pollution, Indoor | 1 | 2014 | 41 | 0.470 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 864 | 0.470 |
Why?
|
Safety | 1 | 2014 | 48 | 0.460 |
Why?
|
Breast Neoplasms | 2 | 2015 | 1502 | 0.460 |
Why?
|
Social Perception | 1 | 2014 | 62 | 0.450 |
Why?
|
Air Pollutants | 1 | 2014 | 94 | 0.450 |
Why?
|
Health Promotion | 1 | 2019 | 653 | 0.430 |
Why?
|
Urban Population | 1 | 2014 | 333 | 0.420 |
Why?
|
Food Supply | 2 | 2023 | 112 | 0.400 |
Why?
|
Aged | 9 | 2024 | 6741 | 0.390 |
Why?
|
Communication | 2 | 2023 | 180 | 0.380 |
Why?
|
Pleural Neoplasms | 3 | 2015 | 53 | 0.370 |
Why?
|
Cannabis | 2 | 2022 | 79 | 0.370 |
Why?
|
New York | 2 | 2023 | 71 | 0.350 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 935 | 0.350 |
Why?
|
Diet | 1 | 2016 | 801 | 0.350 |
Why?
|
Los Angeles | 3 | 2015 | 380 | 0.330 |
Why?
|
Mesothelioma | 3 | 2015 | 144 | 0.330 |
Why?
|
Students, Medical | 2 | 2021 | 130 | 0.320 |
Why?
|
New York City | 2 | 2019 | 220 | 0.300 |
Why?
|
Health Status Disparities | 2 | 2016 | 642 | 0.300 |
Why?
|
Socioeconomic Factors | 3 | 2017 | 1067 | 0.300 |
Why?
|
Schools | 1 | 2009 | 260 | 0.290 |
Why?
|
Environmental Exposure | 1 | 2009 | 216 | 0.280 |
Why?
|
Combined Modality Therapy | 3 | 2015 | 148 | 0.280 |
Why?
|
Prevalence | 3 | 2021 | 1455 | 0.260 |
Why?
|
Receptors, Progesterone | 2 | 2015 | 81 | 0.240 |
Why?
|
Withholding Treatment | 1 | 2024 | 30 | 0.230 |
Why?
|
Receptors, Estrogen | 2 | 2015 | 156 | 0.230 |
Why?
|
Continuity of Patient Care | 1 | 2024 | 94 | 0.220 |
Why?
|
Heart Transplantation | 1 | 2022 | 42 | 0.210 |
Why?
|
Physicians, Women | 1 | 2022 | 4 | 0.210 |
Why?
|
Medicine | 1 | 2022 | 33 | 0.200 |
Why?
|
Schools, Medical | 2 | 2021 | 198 | 0.200 |
Why?
|
Risk Factors | 3 | 2021 | 3562 | 0.200 |
Why?
|
Hepacivirus | 1 | 2021 | 62 | 0.200 |
Why?
|
Poisson Distribution | 1 | 2021 | 38 | 0.190 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 9 | 0.190 |
Why?
|
Lung Neoplasms | 2 | 2015 | 358 | 0.190 |
Why?
|
Masks | 1 | 2020 | 11 | 0.190 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 38 | 0.190 |
Why?
|
Environmental Monitoring | 2 | 2014 | 192 | 0.180 |
Why?
|
Hepatitis C | 1 | 2021 | 125 | 0.180 |
Why?
|
Health | 1 | 2020 | 30 | 0.180 |
Why?
|
Perception | 1 | 2021 | 195 | 0.180 |
Why?
|
Medicaid | 1 | 2021 | 109 | 0.170 |
Why?
|
Education, Medical | 1 | 2021 | 104 | 0.170 |
Why?
|
Faculty | 1 | 2020 | 94 | 0.170 |
Why?
|
Heart Failure | 1 | 2022 | 235 | 0.170 |
Why?
|
Medicare | 1 | 2021 | 195 | 0.170 |
Why?
|
Education, Medical, Undergraduate | 1 | 2020 | 80 | 0.170 |
Why?
|
Biomedical Research | 1 | 2024 | 400 | 0.170 |
Why?
|
Patient Compliance | 1 | 2021 | 212 | 0.170 |
Why?
|
Bankruptcy | 1 | 2019 | 1 | 0.170 |
Why?
|
Ownership | 1 | 2019 | 11 | 0.170 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 78 | 0.160 |
Why?
|
Multivariate Analysis | 2 | 2017 | 583 | 0.160 |
Why?
|
Housing | 1 | 2019 | 59 | 0.160 |
Why?
|
Survivors | 1 | 2019 | 136 | 0.160 |
Why?
|
Rescue Work | 1 | 2017 | 5 | 0.150 |
Why?
|
Occupations | 1 | 2017 | 23 | 0.150 |
Why?
|
Age Factors | 3 | 2015 | 1033 | 0.150 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 225 | 0.150 |
Why?
|
Survival Analysis | 2 | 2016 | 325 | 0.140 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 803 | 0.140 |
Why?
|
Puerto Rico | 1 | 2021 | 1378 | 0.140 |
Why?
|
Sweetening Agents | 1 | 2016 | 12 | 0.140 |
Why?
|
Child | 2 | 2015 | 3131 | 0.140 |
Why?
|
Esophagectomy | 1 | 2016 | 6 | 0.140 |
Why?
|
Beverages | 1 | 2016 | 68 | 0.130 |
Why?
|
Trinidad and Tobago | 1 | 2015 | 3 | 0.130 |
Why?
|
Thoracic Surgical Procedures | 1 | 2015 | 3 | 0.130 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 28 | 0.130 |
Why?
|
Vegetables | 1 | 2016 | 147 | 0.130 |
Why?
|
Cockroaches | 1 | 2014 | 7 | 0.120 |
Why?
|
Fruit | 1 | 2016 | 173 | 0.120 |
Why?
|
Incidence | 1 | 2017 | 922 | 0.120 |
Why?
|
Mastectomy | 1 | 2014 | 15 | 0.120 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 127 | 0.120 |
Why?
|
Carcinoma | 1 | 2015 | 96 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 178 | 0.120 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 48 | 0.120 |
Why?
|
Multilevel Analysis | 1 | 2014 | 16 | 0.120 |
Why?
|
Lymphocytes | 1 | 2014 | 118 | 0.120 |
Why?
|
Neutrophils | 1 | 2014 | 131 | 0.120 |
Why?
|
Psychology | 1 | 2014 | 36 | 0.120 |
Why?
|
Adenocarcinoma | 1 | 2016 | 251 | 0.110 |
Why?
|
Women's Health | 1 | 2014 | 145 | 0.110 |
Why?
|
Fungi | 1 | 2014 | 89 | 0.110 |
Why?
|
Cohort Studies | 1 | 2017 | 1492 | 0.110 |
Why?
|
Registries | 1 | 2015 | 335 | 0.110 |
Why?
|
Family Characteristics | 1 | 2014 | 108 | 0.110 |
Why?
|
Models, Theoretical | 1 | 2014 | 217 | 0.110 |
Why?
|
Odds Ratio | 1 | 2014 | 534 | 0.110 |
Why?
|
Regression Analysis | 1 | 2014 | 455 | 0.110 |
Why?
|
Child, Preschool | 1 | 2015 | 1418 | 0.090 |
Why?
|
Inflammation | 1 | 2014 | 618 | 0.090 |
Why?
|
Minority Groups | 1 | 2014 | 596 | 0.080 |
Why?
|
Boston | 1 | 2009 | 22 | 0.080 |
Why?
|
Occupational Exposure | 1 | 2009 | 79 | 0.080 |
Why?
|
Qualitative Research | 2 | 2022 | 446 | 0.080 |
Why?
|
Sex Factors | 3 | 2015 | 898 | 0.080 |
Why?
|
Rats | 1 | 2014 | 3483 | 0.070 |
Why?
|
SEER Program | 2 | 2016 | 91 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2016 | 2379 | 0.060 |
Why?
|
Survival Rate | 2 | 2015 | 311 | 0.060 |
Why?
|
American Heart Association | 1 | 2023 | 21 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2024 | 88 | 0.060 |
Why?
|
Mice | 1 | 2014 | 5913 | 0.060 |
Why?
|
Research Personnel | 1 | 2024 | 155 | 0.050 |
Why?
|
Masculinity | 1 | 2022 | 17 | 0.050 |
Why?
|
Intention | 1 | 2022 | 94 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2023 | 276 | 0.050 |
Why?
|
Problem-Based Learning | 1 | 2021 | 32 | 0.050 |
Why?
|
Prejudice | 1 | 2021 | 110 | 0.040 |
Why?
|
Hypercholesterolemia | 1 | 2019 | 38 | 0.040 |
Why?
|
Cities | 1 | 2019 | 63 | 0.040 |
Why?
|
Animals | 1 | 2014 | 15081 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2020 | 1130 | 0.040 |
Why?
|
Cognition | 1 | 2019 | 398 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2015 | 275 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2014 | 46 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 1378 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 441 | 0.030 |
Why?
|
Prognosis | 1 | 2015 | 739 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 974 | 0.030 |
Why?
|
Smoking | 1 | 2019 | 940 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2016 | 1369 | 0.030 |
Why?
|
Hypertension | 1 | 2019 | 796 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2016 | 2026 | 0.020 |
Why?
|
Camacho-Rivera's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_